Kristin Babb, PA
Medical · Atlantic, IANPI 1598843831
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $13,500 of the $16,246 with a category attached, or 83.1%. ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) accounts for 87.9% of it on its own, with 22 other manufacturers making up the rest. Reporting peaked in 2021 at $14,893 and has fallen 99.3% since, to $109 in 2025. Among medical clinicians in IA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 73 payments — averaging $222.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$14K
- Boston Scientific$474
- Novartis$170
- Cvrx, Inc.$145
- Edwards Lifesciences$135
- Medtronic$131
- plus $908 from 17 others
What the payments were for
- Speaking & faculty fees$13,50083%
- Food & beverage$2,74517%
- Education$10%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 26 | $14,284 |
| Boston Scientific | 4 | $474 |
| Novartis | 10 | $170 |
| Cvrx, Inc. | 1 | $145 |
| Edwards Lifesciences | 2 | $135 |
| Medtronic | 3 | $131 |
| Abbott | 2 | $123 |
| Sanofi-aventis U.S. LLC | 1 | $122 |
| Philips North America LLC | 1 | $112 |
| E.r. Squibb & Sons, L.L.C. | 6 | $101 |
| Boehringer Ingelheim | 1 | $79 |
| Johnson & Johnson | 3 | $71 |
| Actelion Pharmaceuticals US, Inc. | 1 | $56 |
| Merck | 3 | $54 |
| Impulse Dynamics (USA) Inc. | 1 | $35 |
| Urgo Medical North America, LLC | 1 | $29 |
| Biosense Webster, Inc. | 1 | $28 |
| Kerecis Limited | 1 | $21 |
| AstraZeneca | 1 | $19 |
| Altathera Pharmaceuticals LLC | 1 | $17 |
| Bardy Diagnostics, Inc. | 1 | $15 |
| Lantheus Medical Imaging, Inc. | 1 | $14 |
| Elutia, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LifeVest$13,727
- WATCHMAN FLX$149
- VIGILANT X4 CRT-D$145
- Barostim Neo System$145
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve$134
- Watchman$132
- (7996) US Performance Serv$112
- Micra$111
- ENSITE PRECISION$100
How this compares
$16,246 in reported general payments places this provider in the 95th percentile of 141 medical providers in Iowa.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 76 | $70,230 |
| EntrestoSacubitril/Valsartan | 41 | $27,528 |
| JardianceEmpagliflozin | 17 | $11,099 |
| Repatha SureclickEvolocumab | 18 | $11,055 |
| XareltoRivaroxaban | 11 | $9,555 |
| Bumetanide | 23 | $1,049 |
| Metoprolol Succinate | 89 | $859 |
| Atorvastatin Calcium | 49 | $670 |
| Potassium Chloride | 24 | $483 |
| Torsemide | 12 | $254 |
| Spironolactone | 32 | $183 |
| Furosemide | 45 | $168 |
| Rosuvastatin Calcium | 30 | $167 |
| Losartan Potassium | 37 | $160 |
| Amlodipine Besylate | 16 | $118 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| NovartisEntresto | $170 | $27,52841 claims |
| Boehringer IngelheimJardiance | $79 | $11,09917 claims |
| Johnson & JohnsonXarelto | $71 | $9,55511 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 141 medical providers in Iowa.
Other medical in Atlantic
- Patricia ArasonWest Des Moines$119K
- Maria SonnackIowa City$100K
- Laura QuinnetteCouncil Bluffs$14K
- Laurie HughellUrbandale$9K
- Elizabeth McCullochWest Des Moines$6K
- Jordan GreinerPella$6K
- Samantha SmithBrooklyn$5K
- Emily EricksonDes Moines$5K
- Jennifer VandivierWest Des Moines$5K
- Emily HoffmanWest Des Moines$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.